ArticleJournal for immunotherapy of cancer2024

Mutation-guided chemotherapy-free strategy in first-line immunotherapy for low PD-L1-expressing non-squamous NSCLC.

Hui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.